Core Insights - The Chinese cosmetics market is undergoing a significant paradigm shift, moving from "scale expansion" to "quality leadership" as it surpasses a market size of 1 trillion yuan and domestic brands exceed international ones in sales [1] - HBN, a skincare brand that has filed for an IPO in Hong Kong, exemplifies this shift by focusing on "slow research-driven efficacy," providing a model for domestic brands aiming for high-end market penetration [1] Group 1: Market Trends - The transition of domestic cosmetics brands to high-end positioning is a notable trend, involving upgrades in brand positioning, product efficacy, and consumer perception [4] - HBN has capitalized on the rise of ingredient-focused consumers and the popularization of scientific skincare, playing a dual role in market education and category definition [4] Group 2: HBN's Product Development - HBN has pioneered the "early C, late A" skincare formula, launching successful products like the dual retinol night cream and brightening water, establishing itself in the high-end retinol market [5] - The brand's retinol skincare products and α-arbutin essence have ranked first in national sales for three consecutive years from 2022 to 2024, with cumulative sales of over 30 million units by the end of 2025 [5] Group 3: Consumer Engagement - HBN has accumulated over 4.6 million high-repeat purchase users, with average transaction values gradually increasing; its repurchase rates on platforms like Tmall and Douyin are approximately 35.4% and 44.0%, respectively [7] Group 4: Research and Development - HBN's commitment to "slow research" has built a systematic innovation capability, driving the brand towards high-end positioning [8] - The company has established a complete research loop from basic research to raw material innovation and efficacy verification, with a research team of 103 professionals across various fields [8][10] - HBN has published over 50 international SCI papers, ranking first among domestic skincare brands in terms of publications as the first author [8] Group 5: Efficacy Verification and Industry Contribution - HBN has developed a comprehensive "full-link multi-dimensional cross-validation system" for product efficacy, being the only Chinese skincare brand to conduct efficacy testing through international authoritative institutions [10] - The brand is also advocating for the establishment of a scientific evaluation system for cosmetic efficacy evidence, marking its transition from a market participant to a contributor to high-quality industry development [10] - This shift signifies HBN's role in defining industry standards and its commitment to high-end brand development through continuous investment in research and innovation [10]

Core Viewpoint - HBN has established itself as a leading domestic skincare brand in China, particularly known for its effective retinol products and the "early C, late A" skincare philosophy, and is now seeking to go public on the Hong Kong Stock Exchange [1][3]. Group 1: Brand Development and Market Position - HBN was founded in 2019 and chose to focus on the challenging retinol market, which was dominated by international brands, by emphasizing ingredient transparency and authoritative evidence [3][4]. - The brand has successfully positioned itself in the market by introducing a comprehensive product line that includes retinol-based skincare products, achieving the highest sales in its category from 2022 to 2024 [4][6]. Group 2: Research and Development Strategy - HBN has invested heavily in R&D and established a comprehensive verification system to ensure that all product claims are backed by clinical data, making it the only Chinese skincare brand to conduct efficacy testing through international authorities [6][7]. - The company has developed a sustainable innovation system that allows for the efficient reuse of research outcomes, leading to the continuous launch of new products and categories [7][9]. Group 3: Financial Performance and User Engagement - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of approximately 35.4% on Tmall and 44.0% on Douyin, significantly higher than industry averages [10]. - Financially, HBN reported total revenue of 2.083 billion yuan in 2024, with net profit rising to 129 million yuan, and a 190.3% year-on-year increase in net profit for the first three quarters of 2025 [10].

Group 1 - The core viewpoint of the article highlights the milestone of Shenzhen reaching 600 listed companies, showcasing the strong capital vitality of the Shenzhen market, particularly in the hard technology sector [1] - HBN, a skincare brand focusing on efficacy, has submitted its listing application to the Hong Kong Stock Exchange, representing a new addition to Shenzhen's innovative landscape [1][10] - HBN's founder, Yao Zhenan, has a background in both technology and aesthetics, which has influenced the brand's commitment to genuine efficacy in skincare [3] Group 2 - HBN has established itself as a pioneer in the A-retinol anti-aging segment, with its products ranking first in sales within the category for three consecutive years from 2022 to 2024 [4] - The brand is recognized as the youngest among the top ten domestic skincare brands in China, and it leads the market for improvement-oriented skincare products [4] - HBN's research team consists of 103 members with expertise in various fields, contributing to its innovative product development and industry-leading results [6] Group 3 - HBN is the only skincare brand in China that has undergone efficacy testing by an international authority for its entire product line, reinforcing its commitment to genuine efficacy [8] - The brand has accumulated over 4.6 million repeat customers, with average repurchase rates on platforms like Tmall and Douyin significantly exceeding industry averages [8] - Financially, HBN achieved total revenue of 2.083 billion yuan in 2024, with net profit rising to 129 million yuan, indicating a healthy growth trajectory [9] Group 4 - HBN's upcoming listing on the Hong Kong Stock Exchange marks a new development phase, leveraging its commitment to rigorous research and user trust to set a differentiated path in the beauty and broader consumer sectors [10]

Core Viewpoint - The Chinese skincare brand HBN, under Shenzhen Hujia Technology (Group) Co., Ltd., has submitted its IPO application to the Hong Kong Stock Exchange, highlighting a growth model driven by deep research and rigorous validation, transitioning from "ingredient claims" to "evidence-based support" [1] Group 1: Research-Driven Innovation - HBN was founded in 2019 with the brand philosophy of "making true efficacy a reality," adhering to a long-term development path of "slow research" [4] - As of September 30, 2025, HBN's R&D team will consist of 103 members with diverse backgrounds in dermatology, medicine, cell biology, and synthetic biology, showcasing interdisciplinary collaboration [5] - HBN ranks third among domestic brands in the number of new cosmetic ingredients registered as of September 2025, indicating innovation extending from product formulation to the source ingredient [7] Group 2: Market Position and Product Innovation - HBN has become the youngest brand among the top ten domestic skincare brands in China, leading the market in the segment of improvement skincare products [7] - HBN's A-alcohol skincare products and α-arbutin essence have ranked first in sales within their category for three consecutive years (2022-2024), establishing a clear category advantage [7] Group 3: Building User Trust and Business Health - HBN has developed a comprehensive "full-link multi-dimensional verification system," recognized as the only skincare brand in China to conduct efficacy testing on all products through international authoritative testing agencies [8] - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of approximately 35.4% on Tmall and 44.0% on Douyin, significantly higher than industry averages [9] - In 2024, HBN achieved total revenue of 2.083 billion yuan and a net profit of 129 million yuan, with a net profit margin increasing from 3.5% to 9.6% in the first three quarters of 2025 [9] Group 4: Strategic Significance of IPO - HBN's IPO in Hong Kong marks a critical milestone in its development model of "research-driven innovation and evidence-based trust building," providing a reference for domestic brands to achieve sustainable growth in a competitive market [11]

Core Viewpoint - The Chinese skincare brand HBN, under Shenzhen Hujia Technology (Group) Co., Ltd., has submitted its IPO application to the Hong Kong Stock Exchange, highlighting a growth model driven by deep research and rigorous validation, transitioning from "ingredient claims" to "evidence-based support" in the industry [1] Group 1: Research-Driven Innovation - HBN was founded in 2019 with the brand philosophy of "making true efficacy a reality," adhering to a long-term development path of "slow research" [4] - As of September 30, 2025, HBN's R&D team will consist of 103 members with diverse backgrounds in dermatology, medicine, cell biology, and synthetic biology, showcasing interdisciplinary collaboration [5] - HBN ranks third among domestic brands in the number of new cosmetic ingredients registered as of September 2025, indicating innovation extending from product formulation to the source ingredient [7] Group 2: Market Position and Product Innovation - HBN has become the youngest brand among the top ten domestic skincare brands in China by retail sales in 2024, and it ranks first in the market for improvement-oriented skincare products [7] - HBN's A-retinol skincare products and α-arbutin essence have ranked first in sales within their category for three consecutive years (2022-2024), establishing a clear category advantage [7] - The company has developed a complete product line based on the scientific skincare concept of "Morning C, Evening A," expanding into subcategories like eye creams and neck creams [7] Group 3: Building User Trust and Financial Performance - HBN has established a comprehensive "full-link multi-dimensional verification system," recognized as the only skincare brand in China conducting efficacy testing through international authoritative institutions [8] - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of approximately 35.4% on Tmall and 44.0% on Douyin, significantly higher than industry averages [8] - In 2024, HBN achieved total revenue of 2.083 billion yuan and a net profit of 129 million yuan, with a net profit margin increasing from 3.5% to 9.6% in the first three quarters of 2025, indicating a healthy growth model driven by product strength and trust [9] Group 4: Strategic Significance of IPO - HBN's IPO in Hong Kong marks a critical milestone in its development of a "research-driven innovation and evidence-based trust" model, providing a reference for domestic brands on achieving sustainable growth amid intense market competition [11]

Core Viewpoint - HBN's parent company, Shenzhen Hujia Technology Co., Ltd., has officially submitted an application for a mainboard listing on the Hong Kong Stock Exchange, indicating a continued interest in the Chinese skincare market and the potential for growth in domestic brands [1]. Group 1: Company Overview - HBN is recognized as the youngest player among the top ten domestic skincare brands in China, rapidly rising due to its "early C, late A" product strategy and precise online marketing [5]. - The company was founded in 2019 and has quickly established itself with a focus on "true efficacy," achieving significant market presence in the skincare sector [7]. Group 2: Financial Performance - Hujia Technology's total revenue is projected to increase from 1.948 billion RMB in 2023 to 2.083 billion RMB in 2024, reflecting a growth rate of 6.9%. For the first three quarters of 2025, revenue reached 1.514 billion RMB, a year-on-year increase of 10.2% [9]. - The net profit for 2023, 2024, and the first three quarters of 2025 is reported as 39 million RMB, 129 million RMB, and 145 million RMB, respectively, with a remarkable increase of 232.5% in 2024 compared to 2023 [9]. Group 3: Product and Market Strategy - HBN's primary revenue source is from "improvement-type skincare products," contributing approximately 80% of total revenue in recent years, with a steady increase in the share of "maintenance-type skincare products" [10]. - The company has a high repurchase rate and has seen its net profit double over three years, indicating strong customer loyalty and product effectiveness [7]. Group 4: Sales Channels and Marketing - Hujia Technology's sales are heavily concentrated online, with online channel revenue accounting for 98.6%, 97.7%, and 95.1% of total revenue in 2023, 2024, and the first three quarters of 2025, respectively [12]. - The reliance on online sales has led to high sales expense ratios, with sales and distribution expenses reaching 1.268 billion RMB, 1.238 billion RMB, and 871 million RMB, representing 65.1%, 59.4%, and 57.6% of total revenue [14]. Group 5: Research and Development - Despite HBN's emphasis on "true efficacy," the company's R&D investment is relatively low, with expenditures of 66 million RMB, 58 million RMB, and 40 million RMB for 2023, 2024, and the first three quarters of 2025, respectively, resulting in a decreasing R&D expense ratio [18]. - The majority of Hujia Technology's products are produced through contract manufacturing, raising questions about the extent of its proprietary technology and innovation capabilities [18][24].

Core Viewpoint - The cosmetics industry in China is entering a critical phase of transformation and upgrading, driven by increasing health awareness and aesthetic standards among consumers, with significant advancements showcased at the 35th IFSCC International Congress [1][7]. Group 1: Industry Trends - The Guangdong province, as the largest cosmetics industry hub in China, is leading the transition from "large scale" to "high quality" in the beauty economy through top-level design [2]. - A report indicates that several beauty brands rooted in the Greater Bay Area are now competing closely with international brands in terms of brand influence and innovation [2]. Group 2: HBN Brand Development - HBN, a skincare brand founded in Shenzhen in 2019, emphasizes "visible efficacy" and has established a unique technological advantage in the efficacy skincare sector, particularly in anti-aging [6][8]. - At the IFSCC Congress, HBN presented three significant research papers on anti-aging, including studies on AI-driven skin aging models, which provide theoretical support for future personalized anti-aging strategies [7]. Group 3: Research and Innovation - HBN has developed a comprehensive product line addressing various skincare needs, including anti-aging, brightening, and moisturizing, and has been recognized as a pioneer in advocating for "true efficacy" in skincare products [13][18]. - The brand has completed over 5,000 third-party international efficacy tests across its entire product range, reinforcing its commitment to scientific validation and consumer trust [16]. Group 4: Long-term Research Commitment - HBN has published nearly 40 international SCI journal papers through independent research and collaboration, addressing various fields such as mechanism research and application research [21][22]. - The brand has successfully registered four self-developed efficacy raw materials within two years, establishing a comprehensive raw material matrix that includes traditional Chinese plant extracts and international peptides [22]. Group 5: Brand Philosophy and Future Vision - HBN's approach reflects a commitment to long-term research and innovation, positioning itself as a leader in the high-quality development of the beauty economy and showcasing the value confidence of Chinese brands on a global stage [23].